Alianza de Impacto Latino, the Ismael Cala Foundation, and the PAHO analyzed Covid-19 risks in Latin America

MIAMI, May 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — “Investing in public health systems must be ongoing and extend beyond the Covid-19 pandemic, because that is the only model that can guarantee quality access in every country.” This was one of the conclusions from the virtual event <a target="_blank"…

MIAMI, May 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — “Investing in public health systems must be ongoing and extend beyond the Covid-19 pandemic, because that is the only model that can guarantee quality access in every country.” This was one of the conclusions from the virtual event Latin America and COVID-19, conversations with the WHO/PAHO,” organized by Alianza de Impacto Latino and the Ismael Cala Foundation.

During the event, Ismael Cala, president of the Ismael Cala Foundation, interviewed Dr. Marcos Espinal, director of the Department of Communicable Diseases and Health Analysis of the Pan American Health Organization (PAHO), the Regional Office of the Americas of the World Health Organization (WHO).

They discussed the danger of the virus, but also the existence of other problems in the region, such as domestic violence and mental health, which pose a huge risk to the most vulnerable populations.

They also pointed out the risks of living in a globalized world that is heavily affected by the circulation of fake news, and they recommended preventing disinformation through exhaustive verification of sources.

According to data provided by Dr. Espinal, there are currently more than 180 medical studies on Covid-19 under way. However, no recommendations will be made until efficacy is proved.

Regarding a vaccine, there are currently four research trials under way on humans. A vaccine could be ready in October, but even if it is effective production and distribution to all countries will take time.

Finally, the Pan American Health Organization asked governments to be careful in lifting current social distancing measures to avoid a spike in cases.

Hospital capacity and support for those who remain in isolation should be guaranteed, especially in the poorest countries.

Dr. Marcos Espinal is currently the director of the Department of Communicable Diseases and Health Analysis of the Pan American Health Organization (PAHO), the Regional Office of the Americas of the World Health Organization (WHO). He has worked in matters linked to forgotten, tropical and vector-transmitted diseases, communication of risks and outbreaks, HIV, hepatitis, tuberculosis and STDs.

The Ismael Cala Foundation supports the development of emotional leadership and education of children, adolescents and young adults who are in vulnerable positions in Latin America, and of the Hispanic population in the USA. To achieve its mission, the Foundation has created several programs, including the Scholarship Program. Educational institutions, companies, and other organizations involved in social development have joined forces to promote the education and training of young people by channeling scholarships for courses and/or careers for personal and professional improvement, and thus improve their well-being and social progress.

La Alianza de Impacto Latino is an initiative that seeks to encourage the creation of partnerships for the sustainable growth and development of the Americas. It gathers together leaders from all sectors to support Sustainable Development of the Americas. It was created by the PVBLIC and Ismael Cala foundations.

The webinar can be seen on video here:

 

SOURCE Cala Enterprises Corporation

(Español) Alianza de Impacto Latino, Fundación Ismael Cala y la OPS analizaron riesgos de Covid-19 en América Latina

(Español)

MIAMI, 1 de mayo de 2020 /PRNewswire-HISPANIC PR WIRE/ — “Invertir en los sistemas de salud pública debe convertirse en una constante, más allá de la pandemia de Covid-19, pues será el único modelo que garantizará un acceso de calidad en todos los países”. Esta fue una de las conclusiones del evento virtual <a target="_blank"…

Sorry, this entry is only available in Español.

(Español) Alianza de Impacto Latino, Fundación Ismael Cala y la OPS analizaron riesgos de Covid-19 en América Latina

(Español)

MIAMI, 1 de mayo de 2020 /PRNewswire-HISPANIC PR WIRE/ — “Invertir en los sistemas de salud pública debe convertirse en una constante, más allá de la pandemia de Covid-19, pues será el único modelo que garantizará un acceso de calidad en todos los países”. Esta fue una de las conclusiones del evento virtual <a target="_blank"…

Sorry, this entry is only available in Español.

(Español) Alianza de Impacto Latino, Fundación Ismael Cala y la OPS analizaron riesgos de Covid-19 en América Latina

(Español)

MIAMI, 1 de mayo de 2020 /PRNewswire-HISPANIC PR WIRE/ — “Invertir en los sistemas de salud pública debe convertirse en una constante, más allá de la pandemia de Covid-19, pues será el único modelo que garantizará un acceso de calidad en todos los países”. Esta fue una de las conclusiones del evento virtual <a target="_blank"…

Sorry, this entry is only available in Español.

(Español) Alianza de Impacto Latino, Fundación Ismael Cala y la OPS analizaron riesgos de Covid-19 en América Latina

(Español)

MIAMI, 1 de mayo de 2020 /PRNewswire-HISPANIC PR WIRE/ — “Invertir en los sistemas de salud pública debe convertirse en una constante, más allá de la pandemia de Covid-19, pues será el único modelo que garantizará un acceso de calidad en todos los países”. Esta fue una de las conclusiones del evento virtual <a target="_blank"…

Sorry, this entry is only available in Español.

(Español) Alianza de Impacto Latino, Fundación Ismael Cala y la OPS analizaron riesgos de Covid-19 en América Latina

(Español)

MIAMI, 1 de mayo de 2020 /PRNewswire-HISPANIC PR WIRE/ — “Invertir en los sistemas de salud pública debe convertirse en una constante, más allá de la pandemia de Covid-19, pues será el único modelo que garantizará un acceso de calidad en todos los países”. Esta fue una de las conclusiones del evento virtual <a target="_blank"…

Sorry, this entry is only available in Español.

(Español) Alianza de Impacto Latino, Fundación Ismael Cala y la OPS analizaron riesgos de Covid-19 en América Latina

(Español)

MIAMI, 1 de mayo de 2020 /PRNewswire-HISPANIC PR WIRE/ — “Invertir en los sistemas de salud pública debe convertirse en una constante, más allá de la pandemia de Covid-19, pues será el único modelo que garantizará un acceso de calidad en todos los países”. Esta fue una de las conclusiones del evento virtual <a target="_blank"…

Sorry, this entry is only available in Español.

(Español) Alianza de Impacto Latino, Fundación Ismael Cala y la OPS analizaron riesgos de Covid-19 en América Latina

(Español)

MIAMI, 1 de mayo de 2020 /PRNewswire-HISPANIC PR WIRE/ — “Invertir en los sistemas de salud pública debe convertirse en una constante, más allá de la pandemia de Covid-19, pues será el único modelo que garantizará un acceso de calidad en todos los países”. Esta fue una de las conclusiones del evento virtual <a target="_blank"…

Sorry, this entry is only available in Español.

Reminder: Deadline To File Claims In The Purdue Pharma L.P. Bankruptcy Is June 30, 2020

NEW YORK, May 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — The following is being issued by Prime Clerk, the court-appointed claims and noticing agent.

This is a reminder that Tuesday, June 30, 2020, at 5:00 p.m. (Prevailing Eastern Time) is the deadline or bar date for filing claims in the bankruptcy of Purdue Pharma L.P., a U.S. limited partnership, its general partner and its subsidiaries, including Imbrium Therapeutics L.P., Adlon…

NEW YORK, May 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — The following is being issued by Prime Clerk, the court-appointed claims and noticing agent.

This is a reminder that Tuesday, June 30, 2020, at 5:00 p.m. (Prevailing Eastern Time) is the deadline or bar date for filing claims in the bankruptcy of Purdue Pharma L.P., a U.S. limited partnership, its general partner and its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (“Purdue“).

If someone thinks they have suffered harm from Purdue or its prescription opioids, such as OxyContin, they have the right to file a claim but will lose that right if they don’t file that claim by the bar date.

Filing a claim means you are seeking payment or other compensation from Purdue. Examples of claims that may be filed include claims alleging addiction, dependence, wrongful death, lost wages, loss of spousal relationship benefit for things such as child-rearing and enjoyment of life, or Neonatal Abstinence Syndrome (sometimes referred to as “NAS”).

Claims can be filed by you, your lawyer, a legal guardian, survivors, or relatives of people who have died or are disabled. You may file a claim even if you have received reimbursement from insurance.

Depending on the type of claim you file, you may be required to file a Personal Injury Claimant Proof of Claim Form and supporting documentation. Those claim forms and supporting documentation will be kept highly confidential and not made available to the public. You do not need an attorney to file a proof of claim for you.   

Additionally, partnerships, corporations, joint ventures, trusts, governmental units, and Native American Tribes may also file a proof of claim against Purdue.

Go to www.PurduePharmaClaims.com to find Proof of Claim Forms and a complete list of instructions on how to file a claim.  You will also find a list of the opioids produced, marketed or sold by Purdue.  You can also request a claim form by mail, email or phone:

Purdue Pharma Claims Processing Center
c/o Prime Clerk LLC
850 Third Avenue, Ste. 412, Brooklyn, NY 11232
Email: purduepharmainfo@primeclerk.com
Phone: 1.844.217.0912

 

SOURCE Prime Clerk the Court-Appointed Claims and Noticing Agent

Reminder: Deadline To File Claims In The Purdue Pharma L.P. Bankruptcy Is June 30, 2020

NEW YORK, May 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — The following is being issued by Prime Clerk, the court-appointed claims and noticing agent.

This is a reminder that Tuesday, June 30, 2020, at 5:00 p.m. (Prevailing Eastern Time) is the deadline or bar date for filing claims in the bankruptcy of Purdue Pharma L.P., a U.S. limited partnership, its general partner and its subsidiaries, including Imbrium Therapeutics L.P., Adlon…

NEW YORK, May 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — The following is being issued by Prime Clerk, the court-appointed claims and noticing agent.

This is a reminder that Tuesday, June 30, 2020, at 5:00 p.m. (Prevailing Eastern Time) is the deadline or bar date for filing claims in the bankruptcy of Purdue Pharma L.P., a U.S. limited partnership, its general partner and its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (“Purdue“).

If someone thinks they have suffered harm from Purdue or its prescription opioids, such as OxyContin, they have the right to file a claim but will lose that right if they don’t file that claim by the bar date.

Filing a claim means you are seeking payment or other compensation from Purdue. Examples of claims that may be filed include claims alleging addiction, dependence, wrongful death, lost wages, loss of spousal relationship benefit for things such as child-rearing and enjoyment of life, or Neonatal Abstinence Syndrome (sometimes referred to as “NAS”).

Claims can be filed by you, your lawyer, a legal guardian, survivors, or relatives of people who have died or are disabled. You may file a claim even if you have received reimbursement from insurance.

Depending on the type of claim you file, you may be required to file a Personal Injury Claimant Proof of Claim Form and supporting documentation. Those claim forms and supporting documentation will be kept highly confidential and not made available to the public. You do not need an attorney to file a proof of claim for you.   

Additionally, partnerships, corporations, joint ventures, trusts, governmental units, and Native American Tribes may also file a proof of claim against Purdue.

Go to www.PurduePharmaClaims.com to find Proof of Claim Forms and a complete list of instructions on how to file a claim.  You will also find a list of the opioids produced, marketed or sold by Purdue.  You can also request a claim form by mail, email or phone:

Purdue Pharma Claims Processing Center
c/o Prime Clerk LLC
850 Third Avenue, Ste. 412, Brooklyn, NY 11232
Email: purduepharmainfo@primeclerk.com
Phone: 1.844.217.0912

 

SOURCE Prime Clerk the Court-Appointed Claims and Noticing Agent